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Abstract
The metabolic syndrome (MetS) is a cluster of risk factors for cardiovascular disease asso-
ciated with reduced physical fitness, higher disease burden, and impaired cognitive func-
tions. Little is known about the operation of these risk factors in older adults when
considered comprehensively without relying on the cut-off values of the single MetS com-
ponents. The three main aims of the current study were to: (i) establish a latent metabolic
load factor (MetL), using confirmatory factor analysis (CFA), and representing a continuous
measure of MetL, defined by indicators that are commonly used to separate MetS groups
from healthy individuals; (ii) examine the associations of this MetL factor with objective
health, and cognitive function in men and women; (iii) compare the magnitude of these
associations to those observed for the individual indicators used to define the MetL factor
as well to the classical categorized MetS vs. non-MetS groups. The current analysis is
based on cross-sectional data from 1,609 participants of the Berlin Aging Study II (mean
age = 68.5 years, SD (3.7); 50.1% female). We applied structural equation modeling (SEM)
to establish a latent MetL factor defined by the five indicators commonly used to diagnose
MetS. The latent MetL factor was associated with physician-assessed morbidity and kidney
function (estimated glomerular filtration rate, eGFR) in both men and women, but not with
hand grip strength and lung function (Forced Expiratory Volume in 1 Second (FEV1)). In
addition, we found a negative association between MetL and fluid intelligence among
men. A continuous latent variable approach representing the common variance of MetS
indicators is well suited to foster our understanding of human aging as a systemic
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Introduction
The metabolic syndrome (MetS) defines a cluster of medical conditions (elevated triglycerides,
low high-density-lipoprotein-cholesterol (HDL-C), abdominal obesity, insulin resistance and
elevated blood pressure), which is associated with increased risk of cardiovascular disease and
has a prevalence increasing with age [1,2]. Moreover, several associations between MetS and
non-cardiovascular phenotypes such as osteoporosis, vitamin D deficiency, chronic kidney
disease, reduced physical fitness as indicated by lower grip strength and lung function (Forced
Expiratory Volume in 1 Second, FEV1) have been observed [3–8]. Notably, FEV1 and hand
grip strength have been shown to be excellent predictors of short and long-term outcomes
such as mortality, disability or need for care [9–13]. In addition, some studies investigating the
relationship between MetS and cognitive capacity in patient- or population-based cohorts
have found that cognitive performance is impaired in individuals diagnosed with MetS, partic-
ularly in relation to executive functions [14,15]. Altogether, the majority of studies point to a
negative association of MetS with cognitive performance and brain structure, which is com-
monly attributed to impaired vascular reactivity, neuroinflammation, oxidative stress or
abnormal brain lipid metabolism [14].
The comparability between studies reporting MetS associations with health indicators and
cognitive performance is, however, currently restricted due to the variety of MetS definitions
with variable cut-off values resulting in heterogeneous study groups. A common statement for
the definition of MetS was published in 2009 by Alberti et al., suggesting that any three out of
the five MetS-criteria have to be fulfilled to be diagnosed with MetS [1]. Though there is a
broad consensus on this definition, the mechanisms of MetS are still controversially discussed.
There is a debate on how single indicators relate to the syndrome and which pathogenesis is
central to MetS. Also, fixed cutoff values are difficult to apply to all individuals. As a result,
severity of condition such as intensity and consistency of metabolic impairment can vary
between subjects given the same MetS diagnosis, obscuring the heterogeneity of the condition
[16]. Although differences in men and women with respect to the MetS components and the
development of arteriosclerosis have been recognized, cutoffs for MetS scores are generally not
sex-specific, apart from HDL-C and waist circumference [17–19]. In recent years, studies have
tried to address the methodological limitations evoked by categorical cutoffs by including dif-
ferent approaches such as exploratory and confirmatory factor analyses (EFA; CFA, respec-
tively) to include full continuous information of single indicators to define composites of
MetS. CFA is a statistical approach to verify a sound theoretical concept that is based on
empirical data or theoretical pathways and has already been used in the context of the MetS
[20,21].
Thus, the main purpose of the present study was to model a latent factor employing CFA
representing metabolic load by considering the five indicators as continuous variables that rep-
resent the concept of the MetS [1] and making use of cross-sectional data from generally physi-
cally and cognitive healthy older participants of the Berlin Aging Study II (BASE-II). This
allowed us to investigate in a next step the predictive validity of a continuous metabolic load
factor with respect to physical health indicators and cognitive function. Finally, we investigated
Metabolic load
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the group differences within the categorial MetS definition with respect to physical health and
cognitive function.
Methods
Participants and study design
The study population investigated here consisted of 1,609 healthy older participants of the
BASE-II study (mean age = 68.5 years, SD (3.7); 50.1% female) with valid data on MetS diagno-
sis. Participants were recruited from the greater metropolitan area of Berlin via advertisements
in regional newspapers and public transportation systems as well as through a participant pool
at the Max Planck Institute for Human Development. The medical examination consisted of a
two-day protocol including a comprehensive anamnesis performed by a physician and a wide
array of laboratory and functional tests. Individuals participated in two cognitive testing ses-
sions scheduled one week apart, and were tested in small groups (e.g., about six participants
per group [22,23]). BASE-II was approved by the ethics committee of the Charite´-Universita¨ts-
medizin Berlin (number of the ethical approval: EA2/029/09), and by the ethics committee of
the Max-Planck-Institute for Human Research. All of the participants provided written
informed consent. A detailed description of the overall study design, sampling methods, vari-
ables, and procedures has been described earlier in detail [22,23].
Selection of MetS variables to define a metabolic load factor
We selected only the indicators based on the joint statement on MetS of the International Dia-
betes Federation Task Force [1]: Waist circumference (waist), High Density Lipoprotein
(HDL), fasting blood glucose (BG1), triglycerides (TG), and systolic/diastolic blood pressure.
Waist circumference was assessed using a tape measure at the level of the umbilicus. Systolic/
diastolic blood pressure was measured in a sitting position on the left arm as part of a medical
examination, using an electronic sphygmomanometer (boso-medicus memory, Jung Willin-
gen, Germany). After a fasting period of at least 8 hours, blood was collected from the subjects,
subsequently stored at 4–8˚C and prepared for transport and subsequent measurement on the
same day. The laboratory parameters were analyzed by a certified laboratory (Labor 28 GmbH,
Berlin and Labor Berlin). Serum triglycerides and high-density lipoprotein (HDL) cholesterol
were measured with enzymatic color tests (Roche/Hitachi Modular; device: ACN 435 und
ACN 781). Glucose levels (fasting) were measured using photometric methods and an oral glu-
cose tolerance test (OGTT) was performed according to the WHO-guidelines in subjects with-
out self-reported diabetes mellitus type II (T2D) [23,24].
Objective health variables
Physical fitness represents one’s state of general muscle strength, musculoskeletal capacity, and
general vitality and has been repeatedly indexed with grip strength and forced expiratory vol-
ume [25,26]. In this study, we used continuous information on grip strength and FEV1 as indi-
cators of physical fitness. Grip strength was measured with a dynamometer (Smedley, ranging
from 0 to 100 kg). Participants started with the dominant followed by the non-dominant hand,
and were asked to grasp with as much force as possible. Three measurements for each hand
were requested, with the highest value of each hand being selected for later analysis. Forced
expiratory volume in one second (FEV1) was used as an overall indicator of lung function. We
only analyzed spirometry measurements (using EasyOne Spirometer; ndd Medical Technolo-
gies) with sufficient measurement quality, fully in line with standard procedures following the
guidelines of the American Thoracic Society [27]. Height was measured to the nearest 0.1 cm
Metabolic load
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by using an electronic weighting and measuring station (seca 764, seca, Hamburg, Germany).
Estimated glomerular filtration rate (eGFR) was calculated according to the GFR-FAS formula
(glomerular filtration rate computed by the full age spectrum equation). [28]. Morbidity was
assessed as part of the medical examinations by physicians at the Charite´ university hospital
Berlin. Diagnoses were obtained through participant reports, with select diagnosis (e.g., diabe-
tes mellitus) being verified by additional (blood-laboratory) tests (for details, see [23]). Diagno-
ses were used to compute a morbidity index largely based on the categories of the Charlson
index, which is a weighted sum of moderate to severe, mostly chronic physical illnesses,
including cardiovascular (e.g., congestive heart failure), cancer (e.g., lymphoma). Each disease
is assigned a number based on the severity of the condition (e.g., 1 for myocardial infarct, dia-
betes, ulcer or chronic liver disease, 2 for diabetes with end organ damage, tumor or lym-
phoma, 3 for moderate or severe liver disease, etc.; for details, see [29,30].
Global cognitive functioning
The cognitive battery of BASE-II included the assessment of multiple tasks. Here, we focus on
three main cognitive abilities: episodic memory (EM; indicated by Verbal Learning and Mem-
ory Test, Face–Profession Task, and Scene Encoding), working memory (WM; indicated by
Letter Updating, Number-N-Back, and Spatial Updating), and fluid intelligence (Gf; indicated
by Figural Analogies, Letter Series, and Practical Problems). The chosen tasks varied in proce-
dures and content, consisting of items that relate to verbal, numerical, or figural–spatial infor-
mation. The indicators consisted of the sum of correct responses (Letter Updating, Number-
N-Back, Verbal Learning, Object Location, Practical Problems, Letter Series, Figure Analo-
gies), averaged percentages of correct placements (Spatial Updating) and hits minus false
alarms (Scene Encoding, Face Profession) with higher scores indicating better memory perfor-
mance (for more information, refer [2] and [3]).
Sociodemographic measures and time intervals
We also included several sociodemographic measures in our analysis. Age on the medical
assessment was measured in years since birth, sex was coded as (1) for females and (2) for
males. Education was measured in number of years. The objective health variables were col-
lected about 1 year prior to cognitive testing (mean time difference in years = 1.2 years;
SD = 0.80). To control for individual differences in time elapsing between measurements, we
included the time interval as a control variable in the cognitive analyses. Time intervals
between medical and cognitive assessments were calculated in months for each participant.
Data preparation
To evaluate the latent factor structure of metabolic load and cognitive functioning, we con-
ducted CFA using Mplus ([4]; Version 7). To account for missing data, we used full informa-
tion maximum likelihood algorithm which is implemented in the Mplus software.
Structural equation modeling approach
We used structural equation modeling (SEM) to investigate the relations between MetL, objec-
tive health, and cognitive performance for two reasons. First, SEM enables us to move beyond
modeling at the manifest variable level to modeling the cognitive variables at the construct
level, namely, on latent variables for MetL, WM, EM, and Gf. In doing so, we can account for
and partial out the effects of measurement error, which enhances the validity of our analyses
[31]. Second, SEM offers a generic framework to formalize and test our hypotheses about the
Metabolic load
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potential interrelations of objective health, cognition and MetL. Our focal research question
was whether MetL affects health and cognitive performance in healthy older adults. Due to the
cross-sectional and observational nature of this data set, we cannot clarify the direction of
effects. We aimed to address the question whether the relations between MetL, health and cog-
nition is comparable across gender by means of a multi-group SEM analysis.
Confirmatory factor analysis of cognition and metabolic load
We tested the statistical models in accordance with guidelines for proper execution of CFA
techniques [32]. We relied on standard indices such as the root mean square error of approxi-
mation (RMSEA), standardized root mean square residual (SRMR), and the comparative fit
index (CFI). Commonly accepted thresholds indicating good model fit are RMSEA�0.05,
SRMR�0.05, and CFI�0.95 [33,34].
Model of cognition: We applied a previously established and validated latent factor model
of cognitive functioning within the whole sample which represents individual differences in
WM, EM, and Gf [2].
Model of metabolic load: Based on previous empirical and conceptual work (e.g. Alberti
et al. 2009), we hypothesized that one common factor would describe the relationship of car-
dio-metabolic components of metabolic load best, defined by the following indicators: waist
circumference, triglycerides, fasting blood glucose (BG1), HDL, and systolic and diastolic
blood pressure. All indicators and covariates were standardized to avoid problems in model
estimation within the whole sample. Next, to determine whether the loadings of the single
indicators differ and the metabolic load model is comparable between males and females we
applied measurement invariance tests.
Measurement invariance of metabolic load: In order to determine whether the influences of
all indicators originally selected might show sex-specific differences in the loadings on the met-
abolic load factor, we applied multi-group models to test measurement invariance of the meta-
bolic load model. Measurement invariance tests evaluate the degree to which measurements
conducted in different groups of people (here: male/female) reflect measurement of the same
attributes [35,36]. The test of weak invariance is the least restrictive. Good fit indices indicate
that groups do not differ in their factor structure and factor loadings. Testing of strong invari-
ance requires all assumptions for weak and the same item intercepts across groups. Measure-
ment equivalence of metabolic load was established by calculating the difference between the
CFI-values of the two models (male & female) and accepting equivalence if DCFI<0.1 (as sug-
gested by [36]).
Predicting morbidity and physical health from metabolic load
Based on well-established associations between MetS with physical fitness and disease burden
[3,4,8,14,37], we selected the following objective health parameters: lung function, grip
strength, measures of morbidity, and GFR to validate sex-specific predictive value of the meta-
bolic load factor. In order to investigate simultaneous associations between metabolic load,
lung function, grip strength, morbidity, and GFR we set up a multi-group regression model
for males and females, controlling for age, height, and years of education.
Predicting cognitive functioning from metabolic load
We used latent regression analyses to investigate how EM, WM, and Gf relate to metabolic
load as a function of sex. Missing data were handled using a full information maximum likeli-
hood approach as implemented in the Mplus software. We set up a multi-group structural
equation model to test whether associations between the three-factor model of cognition and
Metabolic load
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metabolic load varied across sex. In addition, three covariates were entered to the SEM as exo-
geneous predictors of cognition and metabolic load: age, years of formal education, and the
time difference between the medical and cognitive sessions.
Predicting morbidity and physical health and cognitive functioning from
single indicators of MetS
To determine whether metabolic load was a more comprehensive predictor of health and cog-
nitive functioning we conducted multiple regression analysis within a multi-group structural
equation model as described above but only by entering the observed scores of the four indi-
vidual components into the regression models simultaneously. Covariates included in this
model were age, years of formal education regressed on all indicators. Height was used to con-
trol for body size on grip strength and lung function.
Differences between MetS/no-MetS groups: Additionally, we applied independent samples-
t-tests to look for differences in health and cognitive outcomes by using Alberti-cut-offs in our
sample.
Results
The sample characteristics and their differences regarding sex are summarized in Table 1. All
demographic variables and indicators showed significant differences between male and female,
except systolic and diastolic blood pressure. In summary, males showed higher age, more years
of education and larger height (all p´s < .005). The groups also differed in all outcome vari-
ables, except eGFR and episodic memory (all p´s < .005, see Table 1).
The intercorrelations of the variables under study are presented in Table 2. The indicators
used to define metabolic load showed a moderate association among each other, suggesting that
they represent distinct but correlated components of metabolic load. In our sample, 594 partici-
pants (31% female) were diagnosed with MetS according to Alberti et al. 2009 (see Table 1).
CFA of metabolic load
The CFA of Model 1 resulted in a good Model fit (χ2(8) = 9.7; CFI = 1.0; RMSEA = 0.012;
SRMR = 0.010). Waist circumference and triglycerides as well as systolic and diastolic blood
pressure were allowed to be correlated. The selected indicators loaded significantly on the met-
abolic load factor (standardized estimates of path loadings: waist = .194; HDL = -.551, TG =
.789; BZP1 = .366; p< .05) except systolic and diastolic blood pressure (standardized estimates
of path loadings for RRsys: .038; RRdiast = .039 p>.200), which is not unusual and in accor-
dance with prior findings [38,39]. Following guidelines for confirmatory factor analyses, we
thus excluded blood pressure as indicators of metabolic load.
In the final Model 2 all remaining indicators loaded significantly on the metabolic load fac-
tor and provided a good model fit (χ2(2) = .23; CFI = 1.00; RMSEA = 0.00; SRMR = 0.004; see
Fig 1; factor loadings are separated for the male and female group). Error terms between waist
circumference and triglycerides were allowed to be correlated.
Measurement equivalence of metabolic load was established by calculating the difference
between the CFI-values of the two models (male & female) and accepting equivalence if
DCFI<0.1 (as suggested by Cheung and Rensvold, 2002).
Predicting morbidity and physical function with metabolic load
As depicted in Fig 2 and Table 2, metabolic load was significantly associated with morbidity,
both in males and females (ßmale = 0.228, and ßfemale = 0.184, p = 0.00; model fit: χ2(60) = 183;
Metabolic load
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CFI = 0.890; RMSEA = 0.53; SRMR = 0.048). From the physical fitness indicators only GFR
showed a negative significant association, both in males and females (ßmale = -0.245, and
ßfemale = -.168, p = 0.00). Grip strength and lung function (FEV1) were not associated with
metabolic load neither in the group of males nor females (p> 0.05).
Predicting cognitive function with metabolic load
We found a negative association between metabolic load and fluid intelligence (Gf) only in the
male group (ß = -0.145; p = 0.019; model fit: χ2(204) = 387; CFI = 0.949; RMSEA = 0.38;
SRMR = 0.037), while the other cognitive domains tested, episodic memory (EM) and working
memory (WM) were not associated with metabolic load (Fig 3).
Associating health and cognitive outcomes with single MetS indicators
The predictions of the five single indicators on (i) health and (ii) cognition are summarized
in the upper part of Table 3. In men, fasting glucose was negatively associated with FEV1
(-.114; p< .00) and triglycerides (-.179; p< .00) and positively with morbidity (.240; p< .00)
after controlling for the effects of age, years of education, and height. In women, waist
Table 1. Descriptive statistics and sex-specific differences among study variables.
Men Women t-test
Mean SD Mean SD t p
(1) Age (60–84 years) 69 3.7 68.5 3.5 2.82 .005��
(2) Education (7–18 years) 14.5 2.8 13.7 2.8 5.03 .000��
(3) Height (cm) 174.9 6.2 162.6 6.0 38.83 .000��
(4) Date difference (weeks) 20 13.4 28 13.6 -11.4 .000��
(5) Waist circumference (cm) 99.6 7.8 102.1 35.1 -2.55 .000��
(6) Triglycerides (mg/dl) 121.1 73.8 104.7 50.9 5.12 .000��
(7) Fasting glucose (mg/dl) 100.1 23.6 92.2 15.0 7.62 .000��
(8) HDL-cholesterol (mg/dl) 55.0 14.5 69.3 4.3 -18.3 .000��
(9) Systolic blood pressure (mmHg) 149.7 60.2 153.4 89.6 -1.01 .314
(10) Diastolic blood pressure (mmHg) 88.7 62.3 92.1 94.3 -.486 .432
(11) MetL factor^ .04 .2 -.04 .1 10.26 .000��
Morbidity & Physical Fitness
(12) Morbidity index 1.3 1.3 1.2 1.2 2.06 .039�
(13) FEV1 (ml) 2974.2 656.7 2130.7 493.9 23.01 .000��
(14) Grip Strength (kg) 37.6 6.1 23.3 4.3 51.6 .000��
(15) eGFR (ml/min/1.73 m2) 70.5 10.7 68.3 10.5 .203 .839
Cognitive Functioning
(12) Working Memory^ 0.5 5.8 -.05 5.2 -.897 .370
(13) Episodic Memory^ -0.1 1.2 .03 1.1 3.18 .002��
(14) Fluid Intelligence^ 0.2 1.4 -.15 1.3 4.03 .000��
MetS Diagnosis cut-off groups in BASE-II Men Women
MetS no-MetS MetS no-MetS
339 (43%) 449 (57%) 255 (31.1%) 566 (68.9%)
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Fig 1. A simplified illustration of CFA results. One-factor solution of metabolic load. The significant standardized factor loading’s (all p’s< .05) are
depicted in numbers on single-headed arrows. Numbers on arrows refer to the factor loading’s for the male (first) and female (second) group.
https://doi.org/10.1371/journal.pone.0208231.g001
Metabolic load
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Fig 2. Latent regression model between the metabolic load factor and indicators of physical health (grip strength,
lung volume ratio, morbidity, and GFR). Double headed arrows presenting covariance and error terms between and
of indicators respectively. Significant standardized regression estimates are depicted in bold numbers on single-headed
arrows. Numbers on arrows refer to the male (above) and female (below) group. �p> .05; ��p> .001.
https://doi.org/10.1371/journal.pone.0208231.g002
Metabolic load
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Fig 3. Latent regression model between the three cognitive factors (EM = episodic memory factor; WM = working
memory factor; GF = Fluid Intelligence) and the metabolic load factor. The covariance between latent factors are
depicted on double headed arrows; Significant standardized regression estimates are depicted in bold numbers on
single-headed arrows. Numbers on arrows refer to the male (first) and female (second) group. �p> .05; ��p> .001.
https://doi.org/10.1371/journal.pone.0208231.g003
Metabolic load
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circumference was negatively correlated with FEV1 (-.279; p< .00) and GFR (-.263; p< .00)
and fasting glucose was positively correlated with morbidity index (.206; p< .00) and
GFR (.166; p < .00). For cognition, fasting glucose was negatively correlated with EM in
women, after controlling for the effects of age, years of education, and testing date difference.
Table 4 depicts differences between MetS diagnosed and healthy groups. By applying the con-
ventional cut-off criteria in our sample, the groups only differed in age, BMI and morbidity
(all p’s< .05).
Discussion
We hypothesized that the established one-latent factor model of metabolic load more compre-
hensively reflects the severity of metabolic condition in our sample of mostly healthy older
adults, in contrast of single indicators of MetS according to Alberti et al [1] and consequently
might be a more fine-grained approach to use in more healthy larger samples regarding
established associations with physical fitness, morbidities and cognitive function. In order to
investigate the hypothesis, we carried out cross-sectional analysis of 1,609 older BASE-II par-
ticipants. We first selected indicators based on the joint statement on MetS of the International
Diabetes Federation Task Force [1], namely waist circumference, triglycerides, fasting blood
glucose, high-density lipoprotein cholesterol and systolic /diastolic blood pressure to define in
a CFA a latent factor for metabolic load. The use of CFA is particularly suitable to reflect the
interplay between these mechanisms, and is rather independent of single MetS constituents
that may be predominant in some subjects diagnosed with MetS according to cut-off values.
We successfully validated the psychometric structure of a one-latent metabolic load factor by
the best fitting factorial solution, suggesting that in a relatively healthy older adult sample the
Table 3. SEM results: Standardized regression coefficents (ß) predicting physical and cognitive functioning from individual and latent MetL components separately
for male and female participants.
SEM Men Women
Grip FEV1 Morbi GFR WM EM Gf Grip FEV1 Morbi GFR WM EM Gf
Single Indicators
(1) Waist circumference (cm) -.043 .011 -.028 -.034 -.057 -.032 -.057 -.023 -.279�� .066 -.089 -.018 -.036 -.048
(2) HDL-cholesterol (mg/dl) -.023 .037 -.070 -.094 -.005 -.045 -.075 -.028 -.000 -.067 -.074 -.075 -.053 -.066
(3) Fasting glucose (mg/dl) -.069 -.114�� .240�� -.008 -.019 -.054 -.051 -.001 -.022 .206�� -.166�� -.011 -.156�� -.001
(4) Triglycerides (mg/dl) -.024 .009 -.073 -.179�� -.034 -.057 -.032 -.022 -.003 .016 -.263�� -.025 -.050 -.095
Covariates
Age (years) -.132�� -.105� -.026 -.350�� -.173�� -.205�� -.130�� -.102�� -.230�� -.095 -.356�� -.121�� -.170�� -.146��
Years of education -.058 -.004 -.001 -.074 -.343�� -.360�� -.409�� -.058 -.033 -.005 -.015 -.268�� -.057 -.332��
Height -.246�� -.238�� - - - - - - - - - - -.278�� .343�� - - - - - - - - - -
Testing date difference - - - - - - - - -.058 -.041 -.070 - - - - - - - - -.017 -.029 -.004
Metabolic load� -.013 -.057 .228�� -.245�� -.043 -.060 -.145�� .033 -.047 .184�� -.168�� -.065 -.025 -.012
Covariates
Age -.124�� -.173�� -.001 -.343�� -.173�� -.202�� -.119�� -.103�� -.094 -.101�� -.363�� -.119�� -.182�� -.150��
Years of education -.057 -.023 -.016 -.071 -.346�� -.356�� -.418�� -.059 -.000 -.005 -.012 -.269�� -.265�� -.333��
Height .256�� -.117�� - - - - - - - - - - -.279�� -.123�� - - - - - - - - - -
Testing date difference - - -.- - - - - - - -.065 -.040 -.081 - - - - - - - - - -.018 -.049 -.005
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indicators we selected significantly contribute to the latent metabolic load factor model. Inter-
estingly, triglyceride and high density lipoproteins showed high loadings on metabolic load
suggesting that blood lipids may drive the associations between, metabolic load, health and
cognition in our sample.
Next, we tested measurement equivalence of the metabolic load factor and found that the
indicators chosen to define metabolic load do not differ across sex by showing comparable
loadings. By using the CFA approach, we were able to demonstrate that the use of continuous
information of MetS indicators (most commonly used as cut-off criteria) is a more compre-
hensive and valid approach to provide a continuous metabolic severity measure for each par-
ticipant without using cut-offs.
This finding reflects the common idea of MetS that the clustering of single components
show common pathomechanisms behind the development of the MetS, which seems also be
true in healthy older adults.
The concept of the MetS is based on a complex interplay between metabolic, inflammatory
and endocrine alterations, which result in a common occurrence of abdominal obesity, insulin
resistance, dyslipidemia and hypertension.[1,17] Particularly insulin resistance is considered
as a pathogenetically significant basis.[17] One consequence of insulin resistance is dyslipide-
mia, which is also manifest in type 2 diabetes. Hypertriglyceridemia is one of the early and fre-
quently detectable consequences of insulin resistance.[40] IR promotes the increase of free
Table 4. Independent 2 sample t-test of group differences of variables within the male group under study sepa-






(1) Age 56.8 /18.7 66.1/10.9 167.4 .000��
58.1 /17.7 66.3/10.1
(2) Education 14.7 /2.7 14.3/2.9 222.2 .683
14.2 /2.8 13.7/2.7
(3) BMI 25.1 /3.2 28.8/3.8 223.9 .047�
24.4 /4.01 29.0/4.5
(4) Morbidity Index 24.80 /1.1 21.4/1.4 116.1 .001��
24.81/1.1 21.2/1.4
(5) FEV1 (ml) 24.731/.1 22.8/.1 222.9 .338
24.742/.1 22.8/.1
(6) Grip Strength (kg) 38.9/7.1 38.4/6.0 222.04 .954
24.8/4.9 23.5/4.8
(7) eGFR (ml/min/1.73 m2) 71.8/10.7 69.4/10.2 222.92 .329
68.8/10.7 69.4/10.2
(8) Working Memory# 24.4/5.9 22.9/5.5 221.2 .270
2 -.2/5.1 2 -.6/5.5
(9) Episodic Memory# 2 -.1/1.2 22.1/1.2 221.3 .248
24.07/1.0 22.02/1.8
(10) Fluid Intelligence# 24.2/1.3 22.2/1.4 221.9 .159
2 -.12/1.2 2 -.19/1.4
#Metabolic load and cognitive functioning indicators are represented as factor scores; eGFR = estimated glomerular
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fatty acids (FFA), since insulin is involved in the inhibition of lipolysis in the liver with a subse-
quent increase in triglyceride levels.[41] Triglyceride-HDL particles can be easily degraded by
the hepatic lipase in the liver, resulting in lower HDL-C levels. The same effect on the lipid
profile is observed in abdominal obesity, as hypertrophy of adipocytes is also associated with
elevated levels of FFA [17]. Obesity is mainly driven by lifestyle habits (dietary habits and phys-
ical inactivity), however, there are also age-related (endocrine) changes and genetic aspects,
which lead to increased fat storage. Recurring activation of insulin secretion due to dietary
habits promotes insulin resistance.[42] Moreover abdominal obesity favors insulin resistance
as a result of the effect of acute elevated FFA on skeletal muscle and glucose uptake in muscle.
[43] Thus, it becomes obvious that pathomechanisms involved in the development of IR, dysli-
pidemia and obesity are closely intertwined and mutually reinforce and influence each other.
Nevertheless, obesity does not inevitably lead to IR, dyslipidemia or hypertension, and these
phenotypes can also occur in normal weight people. In addition, the development of metabolic
impairment differs according to sex [17–19].
Even though the link between the above mechanisms to hypertension is not so apparent,
there is a heaped occurrence of hypertension when dyslipidemia, IR and abdominal obesity
occur. One explanation is an activation of the sympathetic nervous system and consequent
vasoconstriction driven by IR. In addition, a renin-angiotensin system has been proposed in
adipocytes, providing a link to hypertension [44]. As abdominal obesity and IR closely interact
and may act on the development of hypertension, this is also the basis for the connection to
dyslipidemia with hypertension. Nevertheless, systolic and diastolic blood pressure did not
load on the MetL factor in the current analysis. While this is contradictory to several studies
which have shown that blood pressure is part of a one factor structure together with the
anthropometric and metabolic variables constituting the MetS [21,38,39,45–47]. However,
multiple studies reported that they found at least two latent factors underlying the MetS, with
blood pressure representing a separate factor (e.g. [39]). Essential hypertension is the most
common form of hypertension in the general population, particularly in the old. A possible
explanation why hypertension did not load on the MetL factor in BASE-II might be, that
hypertension in our comparably old cohort is based on other mechanisms than the one dis-
cussed above. Two or more factor solutions in the context of MetS have been interpreted with
respect to different pathomechanisms before [38]. Moreover, the development of hypertension
seems to be a late consequence of the mechanisms involved in MetS and a loading of blood
pressure was mainly described in younger subjects than the ones studied here. Additionally,
activation of the sympathetic nervous system and renin-angiotensin system in the old [48] and
its response to stimuli is changing, so these mechanisms might have less effect in the old.[49]
In a second set of analyses, we aimed to validate the metabolic load factor in regard to its
predictive validity of health and cognition. We applied structural equation modeling and
found sex-specific associations between metabolic load and physical fitness, morbidities and
cognition. Metabolic Load was associated with lung function and morbidity in both, males
and females.
In previous studies, different definitions of physical fitness have been used to assess its rela-
tionship with metabolic impairment and MetS, respectively. We decided to use FEV1 and grip
strength to reflect physical fitness, as reported previously [25]. Overall, the association between
MetS and reduced physical fitness is consistent through the studies, showing lower FEV1s in
subjects with metabolic impairment and MetS, independent of definitions used [50,51]. This
has also been confirmed in participants of BASE-II [8]. However, we have shown that this
association is partly driven by single MetS components such as obesity and insulin resistance
[8,51]. Likewise, the relationship between MetS and the prognostically important low grip
strength has been seen before [5,10] but again, might be driven more by certain MetS
Metabolic load
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phenotypes such as insulin resistance or obesity [37]. Otherwise, findings might be driven by
single parameters of MetS that dominate the associations or are predominant in the study pop-
ulation. With regard to our study subjects, we previously reported that insulin resistance and
abdominal obesity were predominant in our subjects with MetS, which might vary in other
populations and lead to different MetS-phenotypes [16,37].
More interestingly, our results showed different associations between males and females in
cognitive domains. In males we found specific associations between metabolic load and fluid
intelligence whereas in the group of females metabolic load was associated with episodic mem-
ory performance. In contrast to the established associations between metabolic risk factors and
health, results regarding the relationship between metabolic impairment or MetS and cogni-
tive function are more complex. The majority of studies found negative associations between
MetS and cognition or brain structure, but there is again evidence that single MetS parameters
might be responsible for this association [52,53,54]. Tournoy et al. reported no association
between MetS and cognitive domains, but an association of diabetes and cognitive impairment
[53]. Other researchers found associations between impaired cognitive function and increased
blood pressure but not with MetS, while other studies revealed no associations or only associa-
tions with the number of MetS components above the cut-off [55–57]. Applying the metabolic
score factor, we found negative associations of metabolic load and Gf in men, which is in line
with the majority of previous findings [14,58]. This indicates that the metabolic load factor
defined here may be suitable to detect early cognitive alterations possibly associated with subtle
metabolic changes in a healthy elderly population. This parameter, which includes the indica-
tors used within the concept of MetS may be applied in clinical research in order to identify
disease developments in early stages of metabolic impairment and MetS, respectively. The con-
tinuous information of the single metabolic indicators merged on metabolic load factor is inde-
pendent of cut-off values and may reflect the development of metabolic impairment based on
the theoretical concept of MetS.
Conclusion
We established a metabolic load factor as a precursor of metabolic impairment in a sample of
older adults originating from the BASE-II study to investigate associations with health and
cognition usually found in MetS. By using a one-latent-factor model of metabolic load we
were able to replicate these known associations. Moreover, we found sex-specific associations
which were more pronounced in males. We were able to demonstrate associations between
morbidity, physical health and cognition and metabolic load, independent of fixed cut-off val-
ues. This approach seemed to be sufficient to qualify early metabolic impairment in rather
healthy older adults and might help longitudinally to understand the evolution of MetS. The
findings underline the importance of early lifestyle and pharmacological interventions that
might set up differently for males and females. This approach might help to improve the
understanding of the association between early stages of MetS, health and cognition in differ-
ent study populations.
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